Assessment of the refractive outcomes of patients with regular corneal astigmatism implanted with high-power toric intraocular lenses.

IF 2.4 3区 医学 Q2 OPHTHALMOLOGY Graefe’s Archive for Clinical and Experimental Ophthalmology Pub Date : 2024-12-01 Epub Date: 2024-07-26 DOI:10.1007/s00417-024-06586-8
Yannis Badri, Antoine Levron, Emilie Agard, Charles-Henry Remignon, Roman Chudzinski, Jeremy Billant, Hugo Bouvarel, Pierre Leroux, Ines Fenniri, Pierre Pradat, Corinne Dot
{"title":"Assessment of the refractive outcomes of patients with regular corneal astigmatism implanted with high-power toric intraocular lenses.","authors":"Yannis Badri, Antoine Levron, Emilie Agard, Charles-Henry Remignon, Roman Chudzinski, Jeremy Billant, Hugo Bouvarel, Pierre Leroux, Ines Fenniri, Pierre Pradat, Corinne Dot","doi":"10.1007/s00417-024-06586-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To describe the refractive outcomes of eyes with high regular corneal astigmatism undergoing age-related cataract surgery.</p><p><strong>Methods: </strong>Astigmatic patients who underwent cataract surgery with implantation of high-power XY1AT HOYA<sup>®</sup> toric lenses (IOLs) (≥ T5) between March 2020 and June 2022 were included. Patients were divided into 2 groups based on the type of Total Corneal Astigmatism (TCA) used for the toric IOL calculation: group 1 = TCA<sup>TK- 700</sup> (TCA measured by the Iol Master 700<sup>®</sup>) and group 2 = TCA<sup>AK- 700</sup> (TCA estimated from the anterior keratometry of the Iol Master 700<sup>®</sup> and using the Abulafia-Koch regression). The best-uncorrected (UDVA) and corrected (CDVA) distance visual acuity, subjective spherical equivalent (SSEq) and subjective residual cylinder (SRC) were assessed at 1 month. The predictability (centroid [CEPA] and mean absolute error in predicted astigmatism [MAEPA]) of the 2 TCA assessment methods was analyzed.</p><p><strong>Results: </strong>96 eyes of 74 patients were included. In the whole cohort, the UDVA was 0.14 ± 0.19 logMAR, the CDVA was 0.04 ± 0.07 logMAR. Postoperative SSEq was - 0.24 ± 0.53D. Postoperative SRC was - 0.48 ± 0.56D. The UDVA, SSEq and SRC did not significantly differ between groups. The MAEPA was significantly better with TCA<sup>AK-700</sup> compared to TCA<sup>TK-700</sup>: 0.58 ± 0.52D versus 0.65 ± 0.55D (p = 0.01). No significant difference was observed for the CEPA (p(x) = 0.09, p(y) = 0.19).</p><p><strong>Conclusions: </strong>XY1AT HOYA<sup>®</sup> toric IOLs are a very good alternative even in case of high toricity. Residual astigmatism predictability is high, it would be better with TCA<sup>AK- 700</sup>. This data should be confirmed with a larger sample of patients.</p>","PeriodicalId":12795,"journal":{"name":"Graefe’s Archive for Clinical and Experimental Ophthalmology","volume":" ","pages":"3915-3923"},"PeriodicalIF":2.4000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Graefe’s Archive for Clinical and Experimental Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00417-024-06586-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/26 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: To describe the refractive outcomes of eyes with high regular corneal astigmatism undergoing age-related cataract surgery.

Methods: Astigmatic patients who underwent cataract surgery with implantation of high-power XY1AT HOYA® toric lenses (IOLs) (≥ T5) between March 2020 and June 2022 were included. Patients were divided into 2 groups based on the type of Total Corneal Astigmatism (TCA) used for the toric IOL calculation: group 1 = TCATK- 700 (TCA measured by the Iol Master 700®) and group 2 = TCAAK- 700 (TCA estimated from the anterior keratometry of the Iol Master 700® and using the Abulafia-Koch regression). The best-uncorrected (UDVA) and corrected (CDVA) distance visual acuity, subjective spherical equivalent (SSEq) and subjective residual cylinder (SRC) were assessed at 1 month. The predictability (centroid [CEPA] and mean absolute error in predicted astigmatism [MAEPA]) of the 2 TCA assessment methods was analyzed.

Results: 96 eyes of 74 patients were included. In the whole cohort, the UDVA was 0.14 ± 0.19 logMAR, the CDVA was 0.04 ± 0.07 logMAR. Postoperative SSEq was - 0.24 ± 0.53D. Postoperative SRC was - 0.48 ± 0.56D. The UDVA, SSEq and SRC did not significantly differ between groups. The MAEPA was significantly better with TCAAK-700 compared to TCATK-700: 0.58 ± 0.52D versus 0.65 ± 0.55D (p = 0.01). No significant difference was observed for the CEPA (p(x) = 0.09, p(y) = 0.19).

Conclusions: XY1AT HOYA® toric IOLs are a very good alternative even in case of high toricity. Residual astigmatism predictability is high, it would be better with TCAAK- 700. This data should be confirmed with a larger sample of patients.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
评估常规角膜散光患者植入高倍散光眼内透镜后的屈光效果。
背景:目的目的:描述接受老年性白内障手术的高规则角膜散光眼的屈光疗效:纳入2020年3月至2022年6月期间接受白内障手术并植入高倍XY1AT HOYA®散光人工晶体(IOLs)(≥ T5)的散光患者。根据散光人工晶体计算所用的角膜总散光(TCA)类型,患者被分为两组:第一组 = TCATK- 700(TCA 由 Iol Master 700® 测得)和第二组 = TCAAK- 700(TCA 由 Iol Master 700® 的前角膜测量和 Abulafia-Koch 回归估算得出)。1 个月后评估最佳未校正(UDVA)和校正(CDVA)距离视力、主观球面等值(SSEq)和主观残余圆柱度(SRC)。分析了两种 TCA 评估方法的可预测性(散光预测中心误差 [CEPA] 和散光预测平均绝对误差 [MAEPA]):结果:共纳入了 74 名患者的 96 只眼睛。所有患者的 UDVA 为 0.14 ± 0.19 logMAR,CDVA 为 0.04 ± 0.07 logMAR。术后SSEq为- 0.24 ± 0.53D。术后 SRC 为 - 0.48 ± 0.56D。各组之间的 UDVA、SSEq 和 SRC 没有明显差异。与 TCATK-700 相比,TCAAK-700 的 MAEPA 明显更好:0.58 ± 0.52D 对 0.65 ± 0.55D (p = 0.01)。CEPA无明显差异(p(x) = 0.09,p(y) = 0.19):结论:XY1AT HOYA® 散光人工晶体即使在散光度数较高的情况下也是一种很好的选择。残余散光的可预测性很高,使用 TCAAK- 700 会更好。这一数据应在更多的患者样本中得到证实。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.40
自引率
7.40%
发文量
398
审稿时长
3 months
期刊介绍: Graefe''s Archive for Clinical and Experimental Ophthalmology is a distinguished international journal that presents original clinical reports and clini-cally relevant experimental studies. Founded in 1854 by Albrecht von Graefe to serve as a source of useful clinical information and a stimulus for discussion, the journal has published articles by leading ophthalmologists and vision research scientists for more than a century. With peer review by an international Editorial Board and prompt English-language publication, Graefe''s Archive provides rapid dissemination of clinical and clinically related experimental information.
期刊最新文献
Assessment of insulin-degrading enzyme inhibitor for the treatment of corneal erosion in a rat model. Association analyses of the measurements of the photopic negative response evoked by two ISCEV protocols. Hyperreflective material evolution patterns during long term anti-VEGF therapy in neovascular age-related macular degeneration. Emerging clinical evidence of a dual role for Ang-2 and VEGF-A blockade with faricimab in retinal diseases. Evaluating anterior segment stability and corneal endothelium after prolene gonioscopy assisted transluminal trabeculotomy (GATT) in open-angle glaucoma.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1